JPMorgan Downgrades NuVasive (NUVA) to Neutral
Tweet
Share
E-mail
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 29
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 29
Join SI Premium – FREE
JPMorgan downgraded NuVasive (NASDAQ: NUVA) from Overweight to Neutral with a price target of $58.00 (from $60.00).
Analyst Robbie Marcus steps the sideline citing limited upside with challenging spine end-market dynamics.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $56.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'
- Rockhopper Exploration Plc. (RKH:LN) (RCKHF) PT Raised to GBP1.35 at Canaccord
- Anixa Biosciences (ANIX) PT Lowered to $6 at H.C. Wainwright
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
